| Treatment-induced tumor dormancy through YAP-mediated transcriptional reprogramming of the apoptotic pathway KJ Kurppa, Y Liu, C To, T Zhang, M Fan, A Vajdi, EH Knelson, Y Xie, ... Cancer cell 37 (1), 104-122. e12, 2020 | 400 | 2020 |
| Heparan sulfate signaling in cancer EH Knelson, JC Nee, GC Blobe Trends in biochemical sciences 39 (6), 277-288, 2014 | 227 | 2014 |
| Intrinsic immunogenicity of small cell lung carcinoma revealed by its cellular plasticity NR Mahadevan, EH Knelson, JO Wolff, A Vajdi, M Saigí, M Campisi, ... Cancer discovery 11 (8), 1952-1969, 2021 | 134 | 2021 |
| STING activation promotes robust immune response and NK cell–mediated tumor regression in glioblastoma models G Berger, EH Knelson, JL Jimenez-Macias, MO Nowicki, S Han, ... Proceedings of the National Academy of Sciences 119 (28), e2111003119, 2022 | 83 | 2022 |
| A bright future for KRAS inhibitors D Bar-Sagi, EH Knelson, LV Sequist Nature Cancer 1 (1), 25-27, 2020 | 66 | 2020 |
| Tumor-derived cGAMP regulates activation of the vasculature M Campisi, SK Sundararaman, SE Shelton, EH Knelson, NR Mahadevan, ... Frontiers in Immunology 11, 2090, 2020 | 54 | 2020 |
| Type III TGF-β receptor promotes FGF2-mediated neuronal differentiation in neuroblastoma EH Knelson, AL Gaviglio, AK Tewari, MB Armstrong, K Mythreye, ... The Journal of clinical investigation 123 (11), 4786-4798, 2013 | 53 | 2013 |
| MPS1 inhibition primes immunogenicity of KRAS-LKB1 mutant lung cancer S Kitajima, T Tani, BF Springer, M Campisi, T Osaki, K Haratani, M Chen, ... Cancer Cell 40 (10), 1128-1144. e8, 2022 | 51 | 2022 |
| Stromal heparan sulfate differentiates neuroblasts to suppress neuroblastoma growth EH Knelson, AL Gaviglio, JC Nee, MD Starr, AB Nixon, SG Marcus, ... The Journal of clinical investigation 124 (7), 3016-3031, 2014 | 51 | 2014 |
| PARP inhibitors in small-cell lung cancer: rational combinations to improve responses EH Knelson, SA Patel, JM Sands Cancers 13 (4), 727, 2021 | 50 | 2021 |
| Phosphorylation of Rab7 by TBK1/IKKϵ regulates innate immune signaling in triple-negative breast cancer JL Ritter, Z Zhu, TC Thai, NR Mahadevan, P Mertins, EH Knelson, BP Piel, ... Cancer research 80 (1), 44-56, 2020 | 49 | 2020 |
| TβRIII/β-arrestin2 regulates integrin α5β1 trafficking, function, and localization in epithelial cells K Mythreye, EH Knelson, CE Gatza, ML Gatza, GC Blobe Oncogene 32 (11), 1416-1427, 2013 | 46 | 2013 |
| Activation of tumor-cell STING primes NK-cell therapy EH Knelson, EV Ivanova, M Tarannum, M Campisi, PH Lizotte, MA Booker, ... Cancer immunology research 10 (8), 947-961, 2022 | 44 | 2022 |
| Plasticity in the absence of NOTCH uncovers a RUNX2-dependent pathway in small cell lung cancer D Hong, EH Knelson, Y Li, YT Durmaz, W Gao, E Walton, A Vajdi, T Thai, ... Cancer research 82 (2), 248-263, 2022 | 29 | 2022 |
| Surgical and peri-operative considerations for brain metastases S Gupta, H Dawood, A Giantini Larsen, L Fandino, EH Knelson, TR Smith, ... Frontiers in Oncology 11, 662943, 2021 | 28 | 2021 |
| The type III TGFβ receptor regulates filopodia formation via a Cdc42-mediated IRSp53–N-WASP interaction in epithelial cells SY Oh, EH Knelson, GC Blobe, K Mythreye Biochemical Journal 454 (1), 79-89, 2013 | 23 | 2013 |
| The Metastatic Breast Cancer (MBC) project: Accelerating translational research through direct patient engagement. N Wagle, C Painter, E Anastasio, M Dunphy, M McGillicuddy, D Kim, ... Journal of Clinical Oncology 35 (15_suppl), 1076-1076, 2017 | 21 | 2017 |
| MET-induced CD73 restrains STING-mediated immunogenicity of EGFR-mutant lung cancer R Yoshida, M Saigi, T Tani, BF Springer, H Shibata, S Kitajima, ... Cancer research 82 (21), 4079-4092, 2022 | 20 | 2022 |
| Heparin-binding epidermal growth factor-like growth factor promotes neuroblastoma differentiation AL Gaviglio, EH Knelson, GC Blobe The FASEB Journal 31 (5), 1903, 2017 | 19 | 2017 |
| Focal expression of mutated tau in entorhinal cortex neurons of rats impairs spatial working memory JJ Ramirez, WE Poulton, E Knelson, C Barton, MA King, RL Klein Behavioural brain research 216 (1), 332-340, 2011 | 19 | 2011 |
David BarbieDana-Farber Cancer InstituteVerified email at partners.org